Health Condition 1: D67- Hereditary factor IX deficiency Health Condition 2: D66- Hereditary factor VIII deficiency Health Condition 3: D681- Hereditary factor XI deficiency
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Already diagnosed cases of hemophilia with factor assay report Patient having APTT level of less then 80sec
Exclusion criteria
Exclusion criteria: Pregnant women and lactating women were not included in the study Patient with Chronic liver diseases HbsAg HCV HIV positive Patient with less than 7 gm percentage of hemoglobin Patients on Factor bypassing agent i e Emicizumab for hemophilia A Patients who are not willing to give their consent Uncontrolled cases of Hypertension DM type II and Hypothyroidism on regular conventional treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding episodes will assessed by Annual Bleeding RateTimepoint: Annual Bleeding Rate assessed at the baseline of study and at the end of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemophilia symptoms also assessed by Gilbert ScoreTimepoint: Gilbert Score will be assessed from baseline 3 months 6 months 9 months and at the end of treatment;Hemophilia Factor assay reportTimepoint: Factor assay before study and at the end of treatment | — |
Countries
India
Contacts
Smt A J Savla Homoeopathic Medical College and Research Institute